Aura Biosciences Inc (AURA)

Nov 26, 2024

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewswire

Nov 26, 2024

Nov 26, 2024

Aura Biosciences CEO to Present at Evercore ISI HealthCONx Conference | AURA Stock News - StockTitan

Nov 26, 2024

Nov 24, 2024

Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7% - MSN

Nov 24, 2024

Nov 21, 2024

When (AURA) Moves Investors should Listen - Stock Traders Daily

Nov 21, 2024

Nov 18, 2024

Aura Biosciences' chief medical officer sells $110,663 in stock By Investing.com - Investing.com Nigeria

Nov 18, 2024

Nov 18, 2024

Aura Biosciences' chief medical officer sells $110,663 in stock - Investing.com

Nov 18, 2024

Nov 18, 2024

HC Wainwright Forecasts Higher Earnings for Aura Biosciences - Defense World

Nov 18, 2024

Nov 18, 2024

HC Wainwright Has Bullish Forecast for AURA FY2024 Earnings - MarketBeat

Nov 18, 2024

Nov 17, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - MarketBeat

Nov 17, 2024

Nov 17, 2024

Aura Biosciences’ (AURA) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 17, 2024

Nov 16, 2024

What is Leerink Partnrs’ Estimate for AURA FY2024 Earnings? - Defense World

Nov 16, 2024

Nov 15, 2024

Leerink Partnrs Has Strong Forecast for AURA FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 15, 2024

Citadel Advisors LLC Reduces Stake in Aura Biosciences Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Target Price at $23.00 - Defense World

Nov 15, 2024

Nov 14, 2024

HC Wainwright Reaffirms Buy Rating for Aura Biosciences (NASDAQ:AURA) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Aura Biosciences Reports Q3 Financial Results - TipRanks

Nov 13, 2024

Nov 13, 2024

Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study - MSN

Nov 13, 2024

Nov 12, 2024

Aura Biosciences : Reports Third Quarter 2024 Financial Results and Business Highlights Form 8 K - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Aura Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of "Buy" from Analysts - MarketBeat

Nov 12, 2024

Nov 07, 2024

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema - The Manila Times

Nov 07, 2024

Oct 31, 2024

One Aura Biosciences Insider Raised Stake By 232% In Previous Year - Yahoo Finance

Oct 31, 2024

Oct 30, 2024

Short Interest in Aura Biosciences, Inc. (NASDAQ:AURA) Decreases By 8.7% - MarketBeat

Oct 30, 2024

Oct 30, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells $98,808.00 in Stock - MarketBeat

Oct 30, 2024

Oct 29, 2024

Aura Biosciences VP sells shares worth $5,938 By Investing.com - Investing.com Australia

Oct 29, 2024

Oct 29, 2024

Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock By Investing.com - Investing.com South Africa

Oct 29, 2024

Oct 29, 2024

Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock - Investing.com

Oct 29, 2024

Oct 29, 2024

Aura Biosciences VP sells shares worth $5,938 - Investing.com

Oct 29, 2024

Oct 23, 2024

Don't Ignore The Insider Selling In Aura Biosciences - Simply Wall St

Oct 23, 2024

Oct 23, 2024

Aura Biosciences (NASDAQ:AURA) Stock Price Down 4.9% After Insider Selling - Defense World

Oct 23, 2024

Oct 22, 2024

Aura Biosciences CFO Julie Feder sells shares worth $302,361 - Investing.com India

Oct 22, 2024

Oct 22, 2024

Aura Biosciences (NASDAQ:AURA) Trading Down 4.9% on Insider Selling - MarketBeat

Oct 22, 2024

Oct 21, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) CFO Sells $302,325.93 in Stock - MarketBeat

Oct 21, 2024

Oct 21, 2024

Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value - Seeking Alpha

Oct 21, 2024

Oct 21, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Receives $23.00 Average Price Target from Analysts - Defense World

Oct 21, 2024

Oct 20, 2024

Long Term Trading Analysis for (AURA) - Stock Traders Daily

Oct 20, 2024

Oct 20, 2024

Aura Biosciences (NASDAQ:AURA) PT Raised to $22.00 at HC Wainwright - Defense World

Oct 20, 2024

Oct 19, 2024

Aura Biosciences stock hits 52-week high at $12.38 By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

Aura Biosciences CEO sells $300,838 in stock By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

Aura Biosciences reports promising early trial results - Investing.com India

Oct 19, 2024

Oct 18, 2024

Insider Selling: Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells 24,992 Shares of Stock - MarketBeat

Oct 18, 2024

Oct 18, 2024

Aura Biosciences CEO sells $300,838 in stock - Investing.com

Oct 18, 2024

Oct 18, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Oct 18, 2024

Oct 18, 2024

Aura Biosciences' Shares Touch 52-Week High on Positive Cancer Drug Data - MarketWatch

Oct 18, 2024

Oct 18, 2024

Aura Biosciences (NASDAQ:AURA) Hits New 12-Month High After Analyst Upgrade - MarketBeat

Oct 18, 2024

Oct 18, 2024

Aura Biosciences stock hits 52-week high at $12.38 - Investing.com

Oct 18, 2024